Profound Reduction in Seizure Frequency (≥75%) Leads to Improved Everyday Executive Function in Patients with Dravet Syndrome at 1 Year Post-treatment with ZX008 (Fenfluramine HCl Oral Solution): Analysis of Data From the Phase 3 Clinical Development Program

被引：0

作者：

Bishop, Kim ^{[1
]}

Isquith, Peter ^{[2
]}

Gioia, Gerard ^{[3
]}

Morrison, Glenn ^{[4
]}

Haney, Douglas ^{[4
]}

Gammaitoni, Arnold ^{[4
]}

机构：

[1] Global Pharma Consultancy LLC, Cranbury, NJ USA

[2] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA

[3] Childrens Natl Hlth Syst, Washington, DC USA

[4] Zogenix Inc, Emeryville, CA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

4257

引用

页数：4